Background. Interleukin 1 receptor associated kinases (IRAKs) play a central role in TLR signaling pathway. Scarce literature has investigated the association of potential functional genetic variants of IRAKs with Hepatitis B Virus-(HBV-) related hepatocellular carcinoma (HCC). Methods. A case-control study with 1,538 HBV-positive HCC patients and 1,465 chronic HBV carriers was conducted to evaluate the effects of common missense variants of IRAK family members on HCC. Proliferation assays and realtime polymerase chain reactions were carried out to evaluate the functions. Multivariable adjusted logistic regression was adopted to estimate effect size and identify risk factors. Results. Association analysis indicated that rs4251545 A allele of IRAK4 (p.Ala428Thr) was positively associated with HBV-related HCC risk (OR = 1.30, 95% CI: 1.09-1.54, = 0.003). Functional annotation indicated that rs4251545 reduced its own expression in liver ( = 0.031). Further molecular functional analysis detected that rs4251545 increased the proliferation rate of L02 cells ( < 0.05). Meanwhile, rs4251545 reduced mRNA expressions of IL-6, IL-8, CXCL-1, and CXCL-2 in L02 cells ( < 0.01). Conclusion. rs4251545 of IRAK4 (p.Ala428Thr) modified the susceptibility to HBV-related HCC via increased proliferation rate and reduced production of inflammatory cytokines and chemokines. Further well-designed experiments are warranted to validate our findings.
Introduction
Globally, HCC was the second leading cause of cancer-related death in men [1] . The incidence rate of HCC varied greatly over the world. East, Southeast Asia, and Sub-Saharan Africa were most vulnerable to HCC, which was consistent with the high prevalence of HBV infection in these regions. China was one of these typical countries and accounted for almost half part of HCC incidence worldwide [1] . The main risk factors of HCC were chronic infections with the hepatitis B or C viruses and/or intake of contamination foods with aflatoxin B1. In particular, hepatitis B virus (HBV) infection was the key risk factor in the pathogenesis of HCC in China [2, 3] . However, it was known that around 1.3%-14.9% HCC was caused by chronic HBV carrier, especially for those who had cancer family history subjects [4, 5] .
Toll-like receptors (TLRs) were one of the conserved and universally expressed innate immunity family members and detected various microbe-associated molecular patterns as the first line of defense [6, 7] . Upon the activation of TLRs, interleukin-1 receptor associated kinase 4 (IRAK4) and IRAK2 were sequentially recruited to the myeloid differentiation primary response gene (MyD88) via its death domain, which further formed a structure called Myddosome [8, 9] . Finally, the NF-B or IRF was activated and released the proinflammatory cytokines, such as IL-6 and IL-8, and interferons [10] . IRAK1 was phosphorylated by IRAK4 and activated the downstream signaling, while IRAK3 was considered as an inhibitor of TLR signaling. However, the precise function of each of them was not very well known.
To date, several documents illustrated that genetic variants of TLRs were involved in the pathogenesis of 2 BioMed Research International HCC [11] [12] [13] . However, only one research found that IRAK2 (p.Leu392Val) carriers had attenuated auto clearance rate of hepatitis C virus (HCV) [14] . Limited systematic researches were performed to evaluate the potential functional variants of IRAKs in the pathogenesis of HCC at population scale, particularly for HBV-related HCC. Therefore, the present study was conducted to explore the association between potential functional single nucleotide polymorphisms (SNPs) of IRAKs and HBV-related HCC with a case-control design (1,538 HBV-positive HCC patients and 1,465 chronic HBV carriers) in Chinese population. Functional assays were further carried out to dissect the molecular mechanisms. Gateway-compatible entry clone of human IRAK4 was a kind gift from Prof. Alexander N. R. Weber (Tuebingen University, Germany). Mutations in IRAK4 were introduced into IRAK4 WT using a Quikchange XL kit (Agilent). PCR conditions were followed the instruction of the kit. Sequences of mutagenesis primers were designed by Agilent and available upon request. Detailed information of site direct mutagenesis was presented in Supplementary Document 1. Finally, the mutation sites were confirmed by the DNA sequencing (Genscript Ltd, Nanjing, China). , and 500 ng RNA was reverse transcribed to cDNA using the Prime-script RT Master Mix (TaKaRa, Kyoto, Japan) in accordance with the manufacturer's instructions. The expression levels of IL-8, IL-6, CXCL-1, and CXCL-2 were detected by using SYBR green labeling kit (TaKaRa, Kyoto, Japan) and performed in ABI 7900 real-time PCR system (Applied Biosystems, Foster city, CA, USA). Each sample was prepared in triplicate, and experiments were done by three independent assays. The results of relative mRNA expression levels were calculated via the equation 2 −ΔCt , in which ΔCt = Ct gene −Ct GAPDH , and further normalized to expression level of empty vector. The sequences of primers were provided in Supplementary Table 1.
Material and Methods

Subjects and Variants Selection
Cell Proliferation Assay.
Statistical Analysis.
The associations between genotypes and HBV-related HCC risks were estimated in an additive model by logistic regression, adjusting for age, sex, smoking, and drinking status. Results were presented as odds ratios (ORs) and 95% confidence intervals (CIs). Homogeneity test among different strata according to selected variables was assessed with 2 -based test. The proliferation and mRNA expression differences were detected by Student'stest (equal variance assumed). All of the statistical analyses were performed in Stata 11.0 (Stata Corporation, College Station, Texas, USA), and statistical significance was set at two-sided ≤ 0.05. c OR (95% CI) and P are derived from logistic regression analysis after adjusting for age, sex, drinking and smoking status. analyzed in subsamples according to various age, sex, smoking status, and drinking status. No significant heterogeneity was observed among different strata after stratification analyses (Table 2) . Meanwhile, the geographic localization might impact on the pathogenesis of HBV-related HCC; the stratification analysis was performed as well. The value was statistically significant in the Southern China [Guangdong, 1.37 (1.13-1.66)] and this difference was attenuated in the Eastern China population (Shanghai). Overall, the whole subjects did not present heterogeneity in terms of geographic locations (Supplementary Table 2 ). Additionally, the result of potential functional annotation from GTEx indicated that only rs4251545 (IRAK4, p.Ala428Thr) reduced its own expression level in liver tissue ( = 0.031, Figure 1) . Hence, further analysis focused on rs4251545. Figure 2 ). Moreover, the mRNA level of HBV was not impacted when comparing the overexpressed IRAK4 428Ala and IRAK4 428Thr into HepG2.2.15 cells (Figure 2 ).
Results
rs4251545 (IRAK4 p.Ala428Thr) Was
rs4251545 (IRAK4 p.Ala428Thr) Increased the Prolifer
rs4251545 (IRAK4 p.Ala428Thr) Attenuated mRNA Expression Levels of IL-6, IL-8, Cxcl-1, and Cxcl-2.
After transfection of IRAK4 428Ala or IRAK4 428Thr 48 h, the mRNA expressions of inflammatory cytokines were assessed by the RT-PCR, such as IL-6, IL-8, CXCL-1, and CXCL-2, respectively. All results indicated that IRAK4 428Thr reduced the expression of inflammatory cytokines and chemokines in L02 cells (all < 0.01), while no significant impact was detected in HepG2 cells (Figure 3 ). 
Discussion
Present study used a case-control design and found an unfavorable association between rs4251545 (IRAK4 p.Ala428Thr) and HBV-related HCC even after adjusting basic social demographic factors, which could be attributed to the diminished signaling activation of NF-B (IL-6 and IL-8) and chemokines (CXCL-1 and CXCL-2). These results indicated that IRAK4 should play an important role in the pathogenesis of HCC, which could be set as a target for the future individual treatment. Our results were consistent with a previous study which found that rs4251545 was associated with 1.68-to 4.99-fold increases in the risk of developing breast cancer in AfricanAmerican women [16] . Moreover, rs4251545 locus occurred in an enhancer/silencer region of the gene, which might impact IRAK4 transcriptional level. This conclusion was consistent with the result from GTEx, which indicated that rs4251545 did reduce the expression level of IRAK4 per se and consequentially reduced the expression of proinflammatory cytokines.
The plausibility of reduced proinflammatory and increased proliferation rate of cells could be attributed to the unbalanced immunity reaction. Several studies found that dysregulation of TLR signaling pathway activation might shift the balance between the production of pro-and antiinflammatory cytokines and would have a profound effect on the risk of infection, chronic inflammation, and cancer [2] . Our previous data found that rs3844283 (IRAK2, p.L392V) was associated with reduced NF-B signaling and IFNand correlated with reduced HCV auto clearance rate and increased risk of chronic HCV infection [14] . Another study indicated that TLR2-196 to -174 del allele carriers had significantly higher HCV viral loads and lower IL-8 induction, using stimulation of monocytes from TLR2-196 to -174 ins/ins homozygous patients [11] . Interestingly, this study pointed out that the distribution of TLR2-196 to -174 del/ins alleles in HCV infected patients without liver cancer and healthy control was identical. They claimed that the polymorphism did not seem to affect the susceptibility of acquirement of HCV infection; it was more likely to have impact on the prognosis of HCV infection. In our analysis, both cases and controls were infected with HBV. We found that the rs4251545 seems to affect the process and outcome of HBV infection. Additionally, the reduced production proinflammatory cytokines and chemokines and increased proliferation rate were only significant in L02 cells, which meant that the rs4251545 of IRAK4 might involve in the initial step of carcinogenesis. When cells were already malignant, the function might be not as dominant as the initial step.
Several limitations in present study should be mentioned: first, several relevant factors that might partially explain the function of immunity at different stage of carcinogenesis, such as cirrhosis status and viral load, were not included into the analysis due to data availability. Second, external population-based validation study should further solidify our results. Third, the population only restricted to Chinese population which would limit the ability of extrapolation. Finally, further comprehensive functional analyses, such as transwell assay, ELISA assay coimmunoprecipitation, or EMSA, should be carried out to deepen our understanding of the molecular mechanism of the pathogenesis in HCC. Overall, it is the first attempt to evaluate the potential functional variants of IRAKs in the pathogenesis of HCC with a moderate sample size. Our study further confirmed that IRAK4 is involved in progression of HBV-related HCC. However, more welldesigned population validation and molecular assays were warranted in the future analysis.
